200 related articles for article (PubMed ID: 9829407)
21. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats.
Schmidt KS; Hacker DV; Kass PH; Barkhoodarian AL
Vet Ophthalmol; 2006; 9(2):137-9. PubMed ID: 16497239
[TBL] [Abstract][Full Text] [Related]
22. Effect of topically applied demecarium bromide and echothiophate iodide on intraocular pressure and pupil size in beagles with normotensive eyes and beagles with inherited glaucoma.
Gum GG; Gelatt KN; Gelatt JK; Jones R
Am J Vet Res; 1993 Feb; 54(2):287-93. PubMed ID: 8430939
[TBL] [Abstract][Full Text] [Related]
23. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
24. Effects of 0.2% brimonidine and 0.2% brimonidine-0.5% timolol on intraocular pressure and pupil size in normal equine eyes.
Von Zup M; Lassaline M; Kass PH; Miller PE; Thomasy SM
Equine Vet J; 2017 Nov; 49(6):810-814. PubMed ID: 28470857
[TBL] [Abstract][Full Text] [Related]
25. Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes.
Wang RF; Podos SM; Mittag TW; Yokoyoma T
Exp Eye Res; 2005 May; 80(5):629-32. PubMed ID: 15862169
[TBL] [Abstract][Full Text] [Related]
26. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
27. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma.
Nakamoto K; Yasuda N
J Glaucoma; 2007; 16(4):352-7. PubMed ID: 17570997
[TBL] [Abstract][Full Text] [Related]
28. Effect of topically applied 2% pilocarpine and 0.25% demecarium bromide on blood-aqueous barrier permeability in dogs.
Krohne SG
Am J Vet Res; 1994 Dec; 55(12):1729-33. PubMed ID: 7887518
[TBL] [Abstract][Full Text] [Related]
29. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
Xu Y; Chen Z; Song J
Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
[TBL] [Abstract][Full Text] [Related]
31. [A clinical observation of the therapeutic effects of pilocarpine gel for treatment of glaucoma].
Yuan J; Wei H
Zhonghua Yan Ke Za Zhi; 1998 May; 34(3):174-7. PubMed ID: 11877182
[TBL] [Abstract][Full Text] [Related]
32. [Bioactivity and effect of a mixture of pilocarpine and lysine on the pupil and intraocular pressure in rabbits].
Veselovský J; Oláh Z; Veselovská Z; Veselá A
Cesk Slov Oftalmol; 1998 Nov; 54(6):353-61. PubMed ID: 9919787
[TBL] [Abstract][Full Text] [Related]
33. Endogenous circadian rhythm of basal pupil size in rabbits.
Liu JH; Gallar J; Loving RT
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2345-9. PubMed ID: 8843919
[TBL] [Abstract][Full Text] [Related]
34. Effects of the topically applied calcium-channel blocker flunarizine on intraocular pressure in clinically normal dogs.
Greller AL; Hoffman AR; Liu C; Ying GS; Vudathala DK; Acland GM; Komáromy AM
Am J Vet Res; 2008 Feb; 69(2):273-8. PubMed ID: 18241026
[TBL] [Abstract][Full Text] [Related]
35. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and patient acceptance of pilocarpine gel.
Goldberg I; Ashburn FS; Kass MA; Becker B
Am J Ophthalmol; 1979 Nov; 88(5):843-6. PubMed ID: 507163
[TBL] [Abstract][Full Text] [Related]
37. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
Wang RF; Gagliuso DJ; Podos SM
J Glaucoma; 2008; 17(1):73-8. PubMed ID: 18303390
[TBL] [Abstract][Full Text] [Related]
38. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
[TBL] [Abstract][Full Text] [Related]
39. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
[TBL] [Abstract][Full Text] [Related]
40. Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma.
Chew PT; Aung T; Aquino MV; Rojanapongpun P;
Ophthalmology; 2004 Mar; 111(3):427-34. PubMed ID: 15019314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
